Toshiba won FDA approval for its Auto-IMT software that measures the thickness of the intima-media layers of the carotid artery, a marker for potential cardiovascular disease. The optional add-on will be available on the company’s Aplio XG, Aplio MX and Xario XG ultrasounds.
Toshiba’s Auto-IMT can determine the thickness of the near and far arterial walls from three segments of the carotid artery: at an optimal angle of incidence and two complementary planes. Auto-IMT traces the two complementary planes automatically and calculates the distance between them. The Auto-IMT uses the collected images following the American Society of Echocardiography’s (ASE) consensus statement for the diagnosis.
Toshiba worked with Midwest Ultrasound, a division of The Christ Hospital in Cincinnati, Ohio, to develop the software tool.
Press release: TOSHIBA ANNOUNCES FDA CLEARANCE OF AUTO-IMT ULTRASOUND SOFTWARE …